Litigation Details for Gilead Sciences, Inc. v. Cipla Limited (D. Del. 2023)
✉ Email this page to a colleague
Gilead Sciences, Inc. v. Cipla Limited (D. Del. 2023)
| Docket | ⤷ Sign Up | Date Filed | 2023-12-29 |
| Court | District Court, D. Delaware | Date Terminated | |
| Cause | 35:271 Patent Infringement | Assigned To | Maryellen Noreika |
| Jury Demand | None | Referred To | |
| Patents | 10,385,067; 9,708,342 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Gilead Sciences, Inc. v. Cipla Limited
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for Gilead Sciences, Inc. v. Cipla Limited (D. Del. 2023)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2024-01-24 | 10 | Leave to File Document | prior to the expiration of U.S. Patent Nos. 9,708,342 and 10,385,067. 2. On or about …follows: 1. This is an action for patent infringement arising under 35 U.S.C. ยงยง 271(a)-…the relief sought. Cipla is a private party to a patent infringement dispute relating to an FDA-approved…to its complaint, which are publicly available patents. 10. The second, third, fourth, fifth…either party. Under the fourth factor, the issue of patent infringement between private parties of a proposed | External link to document |
| 2023-12-29 | 5 | Patent/Trademark Report to Commissioner of Patents | Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,708,342 B2; 10,385,067 B2. (mpb) (…29 December 2023 1:23-cv-01480 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
